Transcardiac increase in tumor necrosis factor-alpha and left ventricular end-diastolic volume in patients with dilated cardiomyopathy

Eur J Heart Fail. 2004 Mar 1;6(2):173-80. doi: 10.1016/j.ejheart.2003.10.004.

Abstract

Background: It remains unclear whether tumor necrosis factor (TNF)-alpha and interleukin-6 (IL-6) are secreted from the failing heart and whether there is a relationship between the transcardiac gradients of these cytokines and left ventricular (LV) remodeling.

Aims: This study evaluated the relationship between transcardiac gradients of cytokines and LV volume and function in congestive heart failure patients with dilated cardiomyopathy (DCM).

Methods and results: We measured the plasma levels of TNF-alpha and IL-6 in the aortic root (Ao) and the coronary sinus (CS) in 60 patients with DCM. There was no difference in plasma IL-6 between the Ao and the CS. However, the plasma TNF-alpha level was significantly higher in the CS than that in the Ao. There was a significant correlation between the transcardiac gradient of plasma TNF-alpha and the LV end-diastolic volume index (LVEDVI) and LV ejection fraction. According to stepwise multivariate analyses, the transcardiac increase of TNF-alpha showed an independent and significantly positive relationship with a large LVEDVI.

Conclusions: These results indicate that the elevated plasma TNF-alpha is partly derived from the failing heart in patients with DCM and that TNF-alpha plays a potential role in structural LV remodeling in patients with DCM.

MeSH terms

  • Adult
  • Aged
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use
  • Cardiomyopathy, Dilated / physiopathology*
  • Cardiomyopathy, Dilated / therapy
  • Case-Control Studies
  • Female
  • Furosemide / therapeutic use
  • Humans
  • Interleukin-6 / biosynthesis*
  • Interleukin-6 / blood
  • Interleukin-6 / metabolism
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Regression Analysis
  • Spironolactone / therapeutic use
  • Stroke Volume
  • Tumor Necrosis Factor-alpha / analysis
  • Tumor Necrosis Factor-alpha / biosynthesis*
  • Tumor Necrosis Factor-alpha / metabolism
  • Ventricular Dysfunction, Left / physiopathology*

Substances

  • Angiotensin-Converting Enzyme Inhibitors
  • Interleukin-6
  • Tumor Necrosis Factor-alpha
  • Spironolactone
  • Furosemide